Rj. De Winter et al., Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction, CARDIO RES, 42(1), 1999, pp. 240-245
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objectives: Elevated concentrations of C-reactive protein (CRP), a non-spec
ific acute phase reactant, and troponin I (TnI), a cardiac-specific marker
of myocardial damage, have been found to be associated with a higher risk f
or cardiac events in patients with an acute coronary syndrome. We evaluated
CRP alone and in combination with TnI for predicting the incidence of majo
r cardiac complications within 6 months in patients with unstable angina or
non-Q-wave infaction (NQMI). Methods: CRP and TnI was measured on admissio
n in patients with unstable angina or NQMI, but results were kept blinded.
Patients were treated according to a conservative management strategy, and
the incidence of major cardiac events within 6 months was assessed. Results
: An abnormal CRP (>5 mg/l) and an abnormal TnI (>0.4 mu g/l) were more fre
quent in patients that suffered a major cardiac event (CRP: 93 vs. 35%, P<0
.0001; TnI: 73 vs. 26%, P<0.001). The incidence of major cardiac events was
higher in patients with an abnormal CRP than in patients with a normal CRP
, both when TnI was abnormal (42 vs. 4.5%, P=0.003) and when TnI was normal
(11 vs. 0%, P=0.014). Mean event-free survival was excellent in patients w
ith both a normal CRP acid TnI, whereas survival was poorest in patients wi
th both an abnormal CRP and TnI (121+/-16 vs. 180 days, P<0.0001). Conclusi
ons: An abnormal CRP on admission in patients with unstable angina or NQMI
is associated with increased incidence of major cardiac events within 6 mon
ths, both in patients with normal and abnormal TnI. CRP and TnI. have indep
endent and additive prognostic value in this patient group, and the combina
tion may be useful for early risk stratification. (C) 1999 Elsevier Science
B.V. All rights reserved.